TRAIL protects against endothelium injury in diabetes via Akt-eNOS signaling

Atherosclerosis

Volumn 237, Issue 2, 2014, Pages 718-724

  Liu, Min ^a   Xiang, Guangda ^a   Lu, Junyan ^a   Xiang, Lin ^a   Dong, Jing ^a   Mei, Wen ^a  

^a WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

Author keywords

Diabetes; Endothelium; Oxidative stress; PI3K Akt; Tumor necrosis factor related apoptosis inducing ligand

Indexed keywords

ACETYLCHOLINE; CATALASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; GLUTATHIONE PEROXIDASE 1; HEMOGLOBIN A1C; MANGANESE SUPEROXIDE DISMUTASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; RECOMBINANT TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STREPTOZOCIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BODY WEIGHT; CELL CULTURE; CHEMOLUMINESCENCE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TREATMENT DURATION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR RING; VASODILATATION; WESTERN BLOTTING;

EID: 84910640757     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.10.013     Document Type: Article

References (28)

1. Park S.M., Schickel R., Peter M.E. Nonapoptotic functions of FADD-binding death receptors and their signaling molecules. Curr. Opin. Cell. Biol. 2005, 17:610-616.
2. Pan G., Ni J., Wei Y.F., Yu G., Gentz R., Dixit V.M. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 1997, 277:815-818.
3. Secchiero P., Gonelli A., Carnevale E., Milani D., Pandolfi A., Zella D., et al. TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways. Circulation 2003, 107:2250-2256.
4. Kavurma M.M., Bennett M.R. Expression, regulation and function of trail in atherosclerosis. Biochem. Pharmacol. 2008, 75:1441-1450.
5. Secchiero P., Candido R., Corallini F., Zacchigna S., Toffoli B., Rimondi E., et al. Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice. Circulation 2006, 114:1522-1530.
6. Di Bartolo B.A., Chan J., Bennett M.R., Cartland S., Bao S., Tuch B.E., et al. TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe (-)/(-) mice. Diabetologia 2011, 54:3157-3167.
7. Xiang G., Zhang J., Ling Y., Zhao L. Circulating level of TRAIL concentration is positively associated with endothelial function and increased by diabetic therapy in the newly diagnosed type 2 diabetic patients. Clin. Endocrinol. (Oxf) 2014, 80:228-234.
8. Bisgin A., Yalcin A.D., Gorczynski R.M. Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients. Diabetes Res. Clin. Pract. 2012, 96:e84-e86.
9. Schoppet M., Sattler A.M., Schaefer J.R., Hofbauer L.C. Osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in atherosclerosis. Atherosclerosis 2006, 184:446-447.
10. Vanhoutte P.M. Endothelial dysfunction: the first step toward coronary arteriosclerosis. Circ. J. 2009, 73:595-601.
11. Schalkwijk C.G., Stehouwer C.D. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin. Sci. (Lond.) 2005, 109:143-159.
12. Yao D., Vlessidis A.G., Gou Y., Zhou X., Zhou Y., Evmiridis N.P. Chemiluminescence detection of superoxide anion release and superoxide dismutase activity: modulation effect of Pulsatillachinensis. Anal. Bioanal. Chem. 2004, 379:171-177.
13. Shen B., Hagiwara M., Yao Y.Y., Chao L., Chao J. Salutary effect of kallistatin in salt-induced renal injury, inflammation, and fibrosis via antioxidative stress. Hypertension 2008, 51:1358-1365.
14. Bustin S.A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J.Mol. Endocrinol. 2000, 25:169-193.
15. Watt V., Chamberlain J., Steiner T., Francis S., Crossman D. TRAIL attenuates the development of atherosclerosis in apolipoprotein E deficient mice. Atherosclerosis 2011, 215:348-354.
16. Corallini F., Celeghini C., Rizzardi C., Pandolfi A., Di Silvestre S., Vaccarezza M., et al. Insulin down-regulates TRAIL expression in vascular smooth muscle cells both invivo and invitro. J.Cell. Physiol. 2007, 212:89-95.
17. Fox C.S., Coady S., Sorlie P.D., Levy D., Meigs J.B., D'Agostino R.S., et al. Trends in cardiovascular complications of diabetes. JAMA 2004, 292:2495-2499.
18. Federici M., Lauro R. Review article: diabetes and atherosclerosis-running on a common road. Aliment. Pharmacol. Ther. 2005, 22(Suppl.2):11-15.
19. Xiang G.D., Xu L., Zhao L.S., Yue L., Hou J. The relationship between plasma osteoprotegerin and endothelium-dependent arterial dilation in type 2 diabetes. Diabetes 2006, 55:2126-2131.
20. Kujiraoka T., Satoh Y., Ayaori M., Shiraishi Y., Arai-Nakaya Y., Hakuno D., et al. Hepatic extracellular signal-regulated kinase 2 suppresses endoplasmic reticulum stress and protects from oxidative stress and endothelial dysfunction. J.Am. Heart Assoc. 2013, 2:e361.
21. Dhar I., Dhar A., Wu L., Desai K. Arginine attenuates methylglyoxal- and high glucose-induced endothelial dysfunction and oxidative stress by an endothelial nitric-oxide synthase-independent mechanism. J.Pharmacol. Exp. Ther. 2012, 342:196-204.
22. Gryglewski R.J., Palmer R.M.J., Moncada S. Superoxideanion is involved in the breakdown of endothelium-dependent vascular relaxing factor. Nature 1986, 320:454-456.
23. Rubanyi G.M., Vanhoutte P.M. Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle. Am. J. Physiol. 1986, 250:H815-H821.
24. Moon D.O., Kim M.O., Lee J.D., Choi Y.H., Kim G.Y. Butein suppresses c-Myc-dependent transcription and Akt-dependent phosphorylation of hTERT in human leukemia cells. Cancer Lett. 2009, 286:172-179.
25. Junhui Z., Xiaojing H., Binquan Z., Xudong X., Junzhu C., Guosheng F. Nicotine-reduced endothelial progenitor cell senescence through augmentation of telomerase activity via the PI3K/Akt pathway. Cytotherapy 2009, 11:485-491.
26. Yang K.S., Lim J.H., Kim T.W., Kim M.Y., Kim Y., Chung S., et al. Vascular endothelial growth factor-receptor 1 inhibition aggravates diabetic nephropathy through eNOS signaling pathway in db/db mice. PLoS One 2014, 9:e94540.
27. Ho F.M., Lin W.W., Chen B.C., Chao C.M., Yang C.R., Lin L.Y., et al. High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-kappa B and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway. Cell. Signal 2006, 18:391-399.
28. Liu M., Xu Y., Han X., Liang C., Yin L., Xu L., et al. Potent effects of flavonoid-rich extract from Rosa laevigata Michx fruit against hydrogen peroxide-induced damage in PC12 cells via attenuation of oxidative stress, inflammation and apoptosis. Molecules 2014, 19:11816-11832.